Nov 05, 2019
PathAI and Bristol Myers-Squibb to Showcase Results From First AI-Powered Analysis of PD-L1 Expression Across Three Phase 3 Trials at SITC 2019
Nov 05, 2019
Compugen Presents Preclinical Data for COM902 Anti-TIGIT Program at SITC 2019
Oct 28, 2019
Applied BioMath, LLC Announces Participation at The Society for Immunotherapy of Cancer (SITC)
Sep 20, 2019
2019 CSCO | CStone releases preliminary results from the Phase Ia trial of CS1003 in Chinese patients with advanced tumors
Sep 16, 2019
Investigational Bispecific Therapeutic Antibodies: 2019 Landscape Evaluation Report
Sep 09, 2019
KAHR Medical Announces Clinical Trial Collaboration to Evaluate DSP107 in Combination With a PD-L1 Checkpoint Inhibitor in Advanced Lung Cancer Patients
Sep 05, 2019
New Study Reinforces Clinical Utility of Combining Tumor Mutation Burden and PD-L1 as Predictive Biomarkers for Immune Checkpoint Inhibitor Therapy
Aug 22, 2019
CStone announces data from trials of CS1001, CS1002 and CS1003 to be released for the first time at 2019 CSCO Annual Meeting
Aug 12, 2019
Phio Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
Aug 07, 2019
Regen BioPharma Inc. Files Immuno-Oncology Patent Application on Synergy of Cannabidiol With NR2F6 Modulation
Jun 06, 2019
Okayama University Research: Improving the Diagnosis of Pancreatic Cancer
Jun 02, 2019
Updated Results on Neoadjuvant PD-1 Blockade with Sintilimab in Resectable Squamous Non-Small Cell Lung Cancer (sqNSCLC) at ASCO, Led by Professor Jie He, Dean of the Cancer Hospital of the Chinese Academy of Medical Sciences
May 31, 2019
Lantheus Announces Strategic Collaboration with NanoMab to Provide a Novel Biomarker for Clinical Development and Management of Immuno-Oncology Therapies
May 21, 2019
Debiopharm Expands its Immuno-Oncology Development Program for Debio 1143, with the First IAP Inhibitor/Nivolumab Combination Trial
May 01, 2019
CStone and Numab announce exclusive regional licensing agreement for ND021, a multi-functional drug candidate and potential next-generation immunotherapy
Apr 23, 2019
Innovent Announces First Patient Dosed in Phase I Clinical Trial of IBI318 Bispecific Antibody in China
Apr 04, 2019
CStone Pharmaceuticals presented poster of pre-clinical result for CS1003 at AACR
Apr 02, 2019
Immune-Oncology Market is Anticipated to Rise at a Significant CAGR Owing to Increase in R&D to Develop Anti-Cancer Drugs Till 2022: Radiant Insights, Inc.
Apr 01, 2019
Inovio Completes Enrollment Ahead of Schedule In Immuno-Oncology Study for Glioblastoma (GBM) with INO-5401 in Combination with Regeneron's PD-1 Inhibitor
Apr 01, 2019
Sierra Reports Late-Breaking Preclinical Data for SRA737 Presented at AACR 2019